Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

Search for glaxosmithkline plc in registrations and monthly communication reports

Refine registrations results by

Status Type Subject matter Government institutions

Refine monthly communication reports results by

Type
Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (80)
Results: 1-50 | Export
  1. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 62 of 62 (2024-03-15 to present)
    Posted: 2024-03-15
    Subject matter details: 18
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  2. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 61 of 62 (2024-02-13 to 2024-03-15)
    Posted: 2024-02-16
    Subject matter details: 18
    Government institutions: 17
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  3. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 60 of 62 (2023-12-31 to 2024-02-13)
    Posted: 2024-01-16
    Subject matter details: 18
    Government institutions: 16
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  4. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 59 of 62 (2023-12-12 to 2023-12-31)
    Posted: 2023-12-14
    Subject matter details: 18
    Government institutions: 16
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 10
  5. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 58 of 62 (2023-11-01 to 2023-12-12)
    Posted: 2023-12-07
    Subject matter details: 18
    Government institutions: 15
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 12
  6. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 57 of 62 (2023-08-21 to 2023-11-01)
    Posted: 2023-08-21
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 12
  7. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 56 of 62 (2023-07-11 to 2023-08-21)
    Posted: 2023-07-11
    Subject matter details: 18
    Government institutions: 11
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 12
  8. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 55 of 62 (2023-06-02 to 2023-07-11)
    Posted: 2023-06-02
    Subject matter details: 18
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  9. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 54 of 62 (2023-01-26 to 2023-06-02)
    Posted: 2023-03-31
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  10. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 53 of 62 (2022-12-01 to 2023-01-26)
    Posted: 2022-12-02
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  11. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 51 of 62 (2022-11-23 to 2022-11-23)
    Posted: 2022-11-24
    Subject matter details: 18
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  12. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 52 of 62 (2022-11-23 to 2022-12-01)
    Posted: 2022-11-28
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  13. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 50 of 62 (2022-09-06 to 2022-11-23)
    Posted: 2022-09-06
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  14. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 49 of 62 (2022-07-18 to 2022-09-06)
    Posted: 2022-07-26
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  15. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 48 of 62 (2022-02-16 to 2022-07-18)
    Posted: 2022-02-16
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  16. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 47 of 62 (2021-11-04 to 2022-02-16)
    Posted: 2021-11-04
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  17. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 46 of 62 (2021-03-01 to 2021-11-04)
    Posted: 2021-03-01
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  18. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 45 of 62 (2021-02-03 to 2021-03-01)
    Posted: 2021-02-03
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  19. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 42 of 62 (2020-09-01 to 2020-09-01)
    Posted: 2020-09-21
    Subject matter details: 15
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  20. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 43 of 62 (2020-09-01 to 2020-09-01)
    Posted: 2020-09-23
    Subject matter details: 15
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  21. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 44 of 62 (2020-09-01 to 2021-02-03)
    Posted: 2020-10-22
    Subject matter details: 15
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  22. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 41 of 62 (2020-07-02 to 2020-09-01)
    Posted: 2020-07-02
    Subject matter details: 15
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  23. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 40 of 62 (2020-01-31 to 2020-07-02)
    Posted: 2020-02-05
    Subject matter details: 14
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  24. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 39 of 62 (2019-09-16 to 2020-01-31)
    Posted: 2019-09-17
    Subject matter details: 14
    Government institutions: 21
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  25. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 38 of 62 (2019-07-03 to 2019-09-16)
    Posted: 2019-07-12
    Subject matter details: 14
    Government institutions: 21
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  26. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 37 of 62 (2019-02-12 to 2019-07-03)
    Posted: 2019-02-13
    Subject matter details: 13
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  27. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 36 of 62 (2019-01-14 to 2019-02-12)
    Posted: 2019-01-16
    Subject matter details: 13
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  28. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 35 of 62 (2018-08-27 to 2019-01-14)
    Posted: 2018-08-27
    Subject matter details: 13
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  29. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 34 of 62 (2018-03-01 to 2018-08-27)
    Posted: 2018-04-17
    Subject matter details: 13
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  30. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Josee Gravelle, General Counsel
    Registration: 33 of 62 (2018-02-01 to 2018-03-01)
    Posted: 2018-03-16
    Subject matter details: 12
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  31. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 32 of 62 (2017-07-27 to 2018-02-01)
    Posted: 2017-08-09
    Subject matter details: 13
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  32. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 31 of 62 (2017-02-13 to 2017-07-27)
    Posted: 2017-02-16
    Subject matter details: 13
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  33. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 30 of 62 (2016-03-08 to 2017-02-13)
    Posted: 2016-03-08
    Subject matter details: 13
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 1
  34. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 29 of 62 (2015-08-18 to 2016-03-08)
    Posted: 2015-08-19
    Subject matter details: 13
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  35. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 28 of 62 (2015-05-06 to 2015-08-18)
    Posted: 2015-05-07
    Subject matter details: 13
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  36. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 27 of 62 (2015-01-15 to 2015-05-06)
    Posted: 2015-01-16
    Subject matter details: 13
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  37. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 26 of 62 (2014-06-10 to 2015-01-15)
    Posted: 2014-06-12
    Subject matter details: 12
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  38. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 25 of 62 (2013-08-14 to 2014-06-02)
    Posted: 2013-08-15
    Subject matter details: 10
    Government institutions: 24
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  39. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 24 of 62 (2012-06-15 to 2013-08-02)
    Posted: 2012-08-09
    Subject matter details: 9
    Government institutions: 25
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 7
  40. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 23 of 62 (2012-05-28 to 2012-06-15)
    Posted: 2012-06-13
    Subject matter details: 9
    Government institutions: 25
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 8
  41. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 22 of 62 (2012-02-17 to 2012-05-28)
    Posted: 2012-02-24
    Subject matter details: 9
    Government institutions: 24
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 8
  42. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Eric Elvidge, Blake, Cassels & Graydon LLP
    Registration: 6 of 6 (2012-01-04 to 2012-11-02)
    Posted: 2012-01-04
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  43. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 21 of 62 (2011-12-08 to 2012-02-17)
    Posted: 2011-12-08
    Subject matter details: 9
    Government institutions: 24
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 8
  44. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 20 of 62 (2011-10-18 to 2011-12-08)
    Posted: 2011-11-14
    Subject matter details: 9
    Government institutions: 23
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 8
  45. ID Biomedical Corporation
    Type: Consultant
    Lobbyist: Eric Elvidge, Blake, Cassels & Graydon LLP
    Registration: 2 of 2 (2011-10-05 to 2013-01-02)
    Posted: 2011-10-05
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  46. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 19 of 62 (2011-06-20 to 2011-10-18)
    Posted: 2011-06-20
    Subject matter details: 9
    Government institutions: 23
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 8
  47. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 18 of 62 (2011-06-09 to 2011-06-20)
    Posted: 2011-06-13
    Subject matter details: 9
    Government institutions: 23
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 7
  48. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 17 of 62 (2010-04-19 to 2011-06-02)
    Posted: 2010-04-20
    Subject matter details: 8
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  49. GlaxoSmithKline
    Type: Consultant
    Lobbyist: KEN BOESSENKOOL, GCI Group Canada
    Registration: 3 of 3 (2010-03-15 to 2010-04-30)
    Posted: 2010-03-19
    Subject matter details: 9
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
  50. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 16 of 62 (2010-02-11 to 2010-04-19)
    Posted: 2010-02-17
    Subject matter details: 8
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 7

Date Modified: